{"id":"gh-treatment-genotropin","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Fluid retention"},{"rate":null,"effect":"Carpal tunnel syndrome"},{"rate":null,"effect":"Arthralgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Genotropin mimics endogenous growth hormone by activating GH receptors on target tissues, promoting linear growth in children, increasing lean body mass, reducing fat mass, and enhancing metabolic function. It stimulates insulin-like growth factor 1 (IGF-1) production, which mediates many of growth hormone's anabolic effects.","oneSentence":"Genotropin is recombinant human growth hormone (somatropin) that binds to growth hormone receptors to stimulate growth, metabolism, and body composition changes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:31:00.640Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Growth hormone deficiency in children"},{"name":"Growth hormone deficiency in adults"},{"name":"Short stature due to Turner syndrome"},{"name":"Chronic kidney disease-related growth failure"},{"name":"Prader-Willi syndrome"}]},"trialDetails":[{"nctId":"NCT06948214","phase":"PHASE3","title":"Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency","status":"RECRUITING","sponsor":"Lumos Pharma","startDate":"2026-04","conditions":"Growth Hormone Deficiency (GHD)","enrollment":150},{"nctId":"NCT07481656","phase":"PHASE4","title":"Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)","status":"NOT_YET_RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2026-04-10","conditions":"Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury","enrollment":160},{"nctId":"NCT00663611","phase":"PHASE1","title":"Growth Hormone Administration and the Human Immune System","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2006-10-19","conditions":"Healthy Volunteers","enrollment":66},{"nctId":"NCT05681299","phase":"PHASE4","title":"Effects of GH and Lirglutide on AgRP","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-05-01","conditions":"Healthy, Growth Hormone Deficiency","enrollment":40},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT02616562","phase":"PHASE2","title":"Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-03-31","conditions":"Growth Hormone Disorder, Growth Hormone Deficiency in Children","enrollment":76},{"nctId":"NCT04697381","phase":"PHASE3","title":"Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-02-09","conditions":"Prader-Willi Syndrome","enrollment":33},{"nctId":"NCT05253287","phase":"PHASE2, PHASE3","title":"Growth Hormone in Decompensated Liver Cirrhosis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-02-01","conditions":"Liver Cirrhosis, Fibrosis, End Stage Liver Disease","enrollment":96},{"nctId":"NCT00803179","phase":"PHASE1","title":"Growth Hormone Therapy for Wasting in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT04066569","phase":"NA","title":"Reproducibility and Utility of OGTT in Acromegaly","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-08-24","conditions":"Acromegaly","enrollment":109},{"nctId":"NCT04020913","phase":"","title":"Skeletal Muscle Effects of GH in Boys","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2019-07-22","conditions":"Growth Hormone Deficiency, Idiopathic Short Stature","enrollment":45},{"nctId":"NCT06037473","phase":"","title":"The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg","status":"RECRUITING","sponsor":"Beijing Children's Hospital","startDate":"2023-08-01","conditions":"Growth Hormone Treatment, Growth Disorders","enrollment":2600},{"nctId":"NCT06294860","phase":"","title":"Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2023-06-19","conditions":"Growth Hormone Deficiency, Short Stature","enrollment":10},{"nctId":"NCT05645211","phase":"","title":"The AgRP and GH/IGF-1 Axis in Children","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-06-10","conditions":"Growth Hormone Deficiency","enrollment":156},{"nctId":"NCT03500913","phase":"","title":"Adipose Tissue and Serum Inflammation in GH Deficiency","status":"COMPLETED","sponsor":"Columbia University","startDate":"2019-05-19","conditions":"Growth Hormone Deficiency","enrollment":19},{"nctId":"NCT03225755","phase":"","title":"Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-08-01","conditions":"Growth Hormone Deficiency","enrollment":7},{"nctId":"NCT06295341","phase":"","title":"Short Stature and Psychological Well-being","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2023-05-10","conditions":"Short Stature, Short; Stature, Psychosocial","enrollment":80},{"nctId":"NCT06900335","phase":"","title":"Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2025-03-01","conditions":"Prader Willi Syndrome, Hyperphagia, Behavior Disorders","enrollment":101},{"nctId":"NCT06825182","phase":"PHASE3","title":"Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-11-07","conditions":"Type 2 Diabetes Mellitus","enrollment":1000},{"nctId":"NCT05447208","phase":"PHASE3","title":"Effect of GH on the Blastocyst Euploid Rate in AMA Patients","status":"RECRUITING","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2022-08-01","conditions":"Preimplantation Genetic Testing, Growth Hormone, Age, Parental","enrollment":400},{"nctId":"NCT02243852","phase":"","title":"Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)","status":"WITHDRAWN","sponsor":"University of Liverpool","startDate":"2014-09","conditions":"Growth Hormone Deficiency","enrollment":""},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT06455956","phase":"","title":"Use of miRNAs in Growth Hormone Deficiency (GHD)","status":"RECRUITING","sponsor":"University of Parma","startDate":"2023-04-13","conditions":"Growth Hormone Deficiency","enrollment":400},{"nctId":"NCT06448195","phase":"PHASE4","title":"Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-01-01","conditions":"Growth Hormone Treatment","enrollment":40},{"nctId":"NCT03344458","phase":"PHASE3","title":"A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial","status":"COMPLETED","sponsor":"Ascendis Pharma A/S","startDate":"2017-12-19","conditions":"Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency","enrollment":298},{"nctId":"NCT04962360","phase":"NA","title":"The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy","status":"RECRUITING","sponsor":"Rabin Medical Center","startDate":"2021-08-01","conditions":"ISS- Idiopathic Short Stature","enrollment":64},{"nctId":"NCT03053687","phase":"NA","title":"Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy","status":"RECRUITING","sponsor":"Rabin Medical Center","startDate":"2017-11-01","conditions":"IGHD - Isolated Growth Hormone Deficiency, Growth Retardation","enrollment":64},{"nctId":"NCT06113952","phase":"","title":"A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2024-01","conditions":"Pediatric Growth Hormone Deficiency","enrollment":""},{"nctId":"NCT05979480","phase":"","title":"The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study)","status":"UNKNOWN","sponsor":"University Hospital Birmingham","startDate":"2023-07-28","conditions":"Adult Growth Hormone Deficiency","enrollment":25},{"nctId":"NCT00673309","phase":"PHASE2, PHASE3","title":"Assessment of Mechanisms of Improved Wound Healing","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2000-07","conditions":"Burns","enrollment":644},{"nctId":"NCT03420144","phase":"PHASE2, PHASE3","title":"Growth Hormone Therapy in Liver Cirrhosis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2018-01-15","conditions":"Cirrhosis, Liver","enrollment":76},{"nctId":"NCT05602090","phase":"PHASE2, PHASE3","title":"Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2022-02-01","conditions":"Poor Ovarian Reserve","enrollment":120},{"nctId":"NCT05144035","phase":"PHASE4","title":"A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2022-04-06","conditions":"Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder","enrollment":138},{"nctId":"NCT00572156","phase":"PHASE2","title":"rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency","status":"TERMINATED","sponsor":"Ipsen","startDate":"2007-12","conditions":"Insulin-like Growth Factor-1 Deficiency","enrollment":106},{"nctId":"NCT02988687","phase":"","title":"Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD","status":"COMPLETED","sponsor":"Garcia, Jose M., MD, PhD","startDate":"2016-11","conditions":"Adult-Onset Growth Hormone Deficiency","enrollment":7},{"nctId":"NCT03038594","phase":"PHASE2, PHASE3","title":"Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-11-01","conditions":"Burns, Growth Hormone Treatment","enrollment":13},{"nctId":"NCT05660356","phase":"EARLY_PHASE1","title":"Growth Hormone Deficiency in Mild Traumatic Brain Injury","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2023-02","conditions":"Growth Hormone Treatment, Growth Hormone Deficiency, Concussion, Mild","enrollment":20},{"nctId":"NCT02973061","phase":"","title":"The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2015-01","conditions":"Growth Hormone Deficiency, Attention Deficit Disorder, Idiopathic Short Stature","enrollment":100},{"nctId":"NCT05281341","phase":"PHASE4","title":"Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-01-13","conditions":"Female Infertility","enrollment":160},{"nctId":"NCT01329757","phase":"PHASE3","title":"Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury","status":"COMPLETED","sponsor":"Hospital Nacional de Parapléjicos de Toledo","startDate":"2011-04","conditions":"Spinal Cord Injury","enrollment":76},{"nctId":"NCT03305016","phase":"PHASE3","title":"A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2017-11-13","conditions":"Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency","enrollment":146},{"nctId":"NCT05089344","phase":"NA","title":"Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2021-10-09","conditions":"Poor Response to Ovulation Induction Poseidon Type IV","enrollment":132},{"nctId":"NCT01861717","phase":"PHASE4","title":"A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.","status":"TERMINATED","sponsor":"Saint John's Cancer Institute","startDate":"2013-05","conditions":"Acromegaly","enrollment":4},{"nctId":"NCT01298180","phase":"PHASE4","title":"Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2009-01","conditions":"Prader-Willi Syndrome, Growth Hormone Deficiency","enrollment":111},{"nctId":"NCT01626833","phase":"PHASE2, PHASE3","title":"Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-03","conditions":"Anorexia Nervosa, Interruption of Growth, Delayed Puberty","enrollment":15},{"nctId":"NCT03616509","phase":"PHASE4","title":"GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2017-06-19","conditions":"Prader-Willi Syndrome","enrollment":30},{"nctId":"NCT00447499","phase":"PHASE3","title":"Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel","status":"COMPLETED","sponsor":"Ipsen","startDate":"2007-04","conditions":"Acromegaly","enrollment":59},{"nctId":"NCT00747604","phase":"","title":"IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex","status":"TERMINATED","sponsor":"Ipsen","startDate":"2006-06","conditions":"Primary Insulin-like Growth Factor-1 Deficiency","enrollment":1378},{"nctId":"NCT02580032","phase":"","title":"Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2015-10-05","conditions":"Growth Disorder, Growth Hormone Deficiency in Children","enrollment":252},{"nctId":"NCT00182091","phase":"NA","title":"Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-08","conditions":"Acromegaly, Growth Hormone Deficiency, Pituitary Disease","enrollment":75},{"nctId":"NCT04529356","phase":"NA","title":"The TMS Treatment for Postoperative Headache in GH Tumor","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2020-09-01","conditions":"Headache, Pituitary Tumor, Acromegaly","enrollment":200},{"nctId":"NCT04508673","phase":"","title":"Impact of GH Measurements on GHD Diagnosis","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2019-04-01","conditions":"Growth Hormone Deficiency","enrollment":41},{"nctId":"NCT02420353","phase":"PHASE2","title":"Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2015-05","conditions":"Rupture of Anterior Cruciate Ligament","enrollment":20},{"nctId":"NCT00766038","phase":"PHASE2","title":"Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-09","conditions":"Traumatic Brain Injury","enrollment":63},{"nctId":"NCT03878992","phase":"NA","title":"Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2019-04-30","conditions":"Growth Hormone Deficiency, Growth Hormone Treatment","enrollment":12},{"nctId":"NCT03672617","phase":"","title":"Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-10-02","conditions":"Growth Hormone Deficiency in Children","enrollment":321},{"nctId":"NCT02049671","phase":"","title":"Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet","status":"UNKNOWN","sponsor":"The Leeds Teaching Hospitals NHS Trust","startDate":"2013-06-01","conditions":"Hypopituitary Adults","enrollment":150},{"nctId":"NCT01438801","phase":"PHASE4","title":"Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)","status":"WITHDRAWN","sponsor":"Ipsen","startDate":"2013-05","conditions":"Idiopathic Short Stature","enrollment":""},{"nctId":"NCT00448747","phase":"PHASE3","title":"Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.","status":"COMPLETED","sponsor":"AEterna Zentaris","startDate":"2007-06","conditions":"Diagnosis of Adult Growth Hormone Deficiency (AGDH)","enrollment":101},{"nctId":"NCT02879747","phase":"PHASE2, PHASE3","title":"Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2003-12","conditions":"Short Stature","enrollment":99},{"nctId":"NCT02199587","phase":"NA","title":"The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test","status":"COMPLETED","sponsor":"Meir Medical Center","startDate":"2014-12-17","conditions":"Precocious Puberty, Growth Hormone Tests","enrollment":58},{"nctId":"NCT01467193","phase":"","title":"The Effect of Dietary Fat Load and Physical Exercise on the Flexibility and Partitioning of Ectopic Lipids.","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2011-08","conditions":"Ectopic Lipids, Insulin Sensitivity, Aerobic Exercise","enrollment":30},{"nctId":"NCT02977091","phase":"","title":"Fitness Level in Short Stature Children and After Growth Hormone Treatment","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2016-12-15","conditions":"Fitness","enrollment":50},{"nctId":"NCT01699308","phase":"PHASE1","title":"Growth Hormone and Brain Functioning After Traumatic Brain Injury","status":"COMPLETED","sponsor":"Joe Springer","startDate":"2009-12-01","conditions":"Traumatic Brain Injury","enrollment":15},{"nctId":"NCT01970800","phase":"NA","title":"The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature","status":"WITHDRAWN","sponsor":"Maimonides Medical Center","startDate":"2013-01","conditions":"Short Stature","enrollment":""},{"nctId":"NCT03525171","phase":"NA","title":"Evalutation of Insulin Sensitivity Through Hyperinsulinemic Clamp in Children With GH Deficiency","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2014-01-01","conditions":"Growth Hormone Deficiency","enrollment":23},{"nctId":"NCT01265017","phase":"PHASE1","title":"Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Sansum Diabetes Research Institute","startDate":"2012-07","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT02114775","phase":"PHASE1","title":"Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2014-12-12","conditions":"Traumatic Brain Injury","enrollment":34},{"nctId":"NCT02766764","phase":"PHASE4","title":"Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-06","conditions":"Subfertility","enrollment":230},{"nctId":"NCT01246219","phase":"PHASE4","title":"Short Stature Related Distress","status":"COMPLETED","sponsor":"Rabin Medical Center","startDate":"2011-10","conditions":"Idiopathic Short Stature, Self Image","enrollment":60},{"nctId":"NCT03033121","phase":"PHASE3","title":"Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2016-01-01","conditions":"Growth Hormone Treatment","enrollment":32},{"nctId":"NCT03237117","phase":"EARLY_PHASE1","title":"Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program","status":"UNKNOWN","sponsor":"Competence Centre on Health Technologies","startDate":"2010-01-01","conditions":"Female Infertility","enrollment":105},{"nctId":"NCT01342146","phase":"PHASE2","title":"Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2006-05","conditions":"Growth Hormone Deficiency","enrollment":101},{"nctId":"NCT01495468","phase":"PHASE3","title":"Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2007-03","conditions":"Growth Hormone Deficiency","enrollment":343},{"nctId":"NCT00001343","phase":"PHASE2","title":"The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1992-12-11","conditions":"Dwarfism, Turner's Syndrome","enrollment":80},{"nctId":"NCT03203356","phase":"","title":"Adrenal Function in GHD Children","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2016-05-30","conditions":"Growth Hormone Treatment, Adrenal; Functional Disturbance","enrollment":30},{"nctId":"NCT03162172","phase":"","title":"Growth Hormone (GH) in Congenital Adrenal Hyperplasia","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-09-15","conditions":"Adrenal Hyperplasia, Congenital","enrollment":25},{"nctId":"NCT02359695","phase":"PHASE1","title":"Low-dose GH Supplementation Increases Clinical Pregnancy Rate","status":"COMPLETED","sponsor":"Centro de Infertilidad y Reproducción Humana","startDate":"2013-10","conditions":"Infertility","enrollment":64},{"nctId":"NCT00174460","phase":"PHASE2","title":"Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age","status":"COMPLETED","sponsor":"Pfizer","startDate":"2005-08","conditions":"Growth Hormone Therapy, Infant, Very Low Birth Weight","enrollment":33},{"nctId":"NCT01367834","phase":"NA","title":"Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome","status":"COMPLETED","sponsor":"Rebecca Knickmeyer Santelli, PhD","startDate":"2010-05","conditions":"Turner Syndrome","enrollment":17},{"nctId":"NCT00376064","phase":"PHASE4","title":"Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-03","conditions":"Acromegaly","enrollment":20},{"nctId":"NCT01734486","phase":"PHASE4","title":"Growth Response in Girls With Turner Syndrome","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1996-09-23","conditions":"Genetic Disorder, Turner Syndrome","enrollment":31},{"nctId":"NCT00097539","phase":"","title":"National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"1985-10","conditions":"Growth Disorders","enrollment":65205},{"nctId":"NCT02801565","phase":"NA","title":"Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2016-02","conditions":"Polycystic Ovary Syndrome","enrollment":208},{"nctId":"NCT02931591","phase":"NA","title":"Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children","status":"UNKNOWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2016-11","conditions":"Small for Gestational Age","enrollment":24},{"nctId":"NCT00372125","phase":"NA","title":"Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome","status":"COMPLETED","sponsor":"Karolinska University Hospital","startDate":"2005-04","conditions":"Prader-Willi Syndrome","enrollment":46},{"nctId":"NCT00134420","phase":"PHASE3","title":"Growth Hormone and Chromosome 18q- and Abnormal Growth","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2001-02","conditions":"Loss of Chromosome 18q, Growth Hormone Deficiency","enrollment":20},{"nctId":"NCT01723748","phase":"NA","title":"Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2012-12","conditions":"Acromegaly, Metabolic Diseases","enrollment":18},{"nctId":"NCT00131378","phase":"NA","title":"Growth Hormone, Cardiovascular Risk, and Visceral Adiposity","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-11","conditions":"Obesity","enrollment":142},{"nctId":"NCT02077348","phase":"NA","title":"Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2014-05","conditions":"Diabetes Mellitus Type I, Ketoacidosis","enrollment":9},{"nctId":"NCT01397500","phase":"PHASE2","title":"Hormone Treatment in Growth Hormone and Testosterone Deficient Patients","status":"TERMINATED","sponsor":"Max-Planck-Institute of Psychiatry","startDate":"2011-11","conditions":"Hormone Deficiency","enrollment":54},{"nctId":"NCT02629926","phase":"","title":"Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors","status":"UNKNOWN","sponsor":"The Leeds Teaching Hospitals NHS Trust","startDate":"2010-10","conditions":"Metabolic Diseases, Cancer","enrollment":60},{"nctId":"NCT01572259","phase":"PHASE3","title":"Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2011-09","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":40},{"nctId":"NCT02507245","phase":"","title":"Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)","status":"COMPLETED","sponsor":"Stefania La Grutta, MD","startDate":"2014-01","conditions":"Growth Hormone Deficiency","enrollment":48},{"nctId":"NCT01204840","phase":"PHASE2","title":"Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Ottawa Fertility Centre","startDate":"2010-09","conditions":"Infertility, Poor Ovarian Reserve","enrollment":38},{"nctId":"NCT00813189","phase":"PHASE3","title":"Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid","status":"COMPLETED","sponsor":"Association REMEDE","startDate":"2005-04","conditions":"Chronic Disease, Glucocorticoid Therapy, Response to, Growth Retardation","enrollment":30},{"nctId":"NCT00396474","phase":"","title":"Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2009-01","conditions":"Infant, Small for Gestational Age","enrollment":""},{"nctId":"NCT00140413","phase":"PHASE4","title":"Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia","status":"COMPLETED","sponsor":"Children's Hospital Los Angeles","startDate":"2004-12","conditions":"Growth Hormone Deficiency, Septo-Optic Dysplasia, Hypopituitarism","enrollment":20},{"nctId":"NCT01302652","phase":"","title":"Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-02","conditions":"Acromegaly","enrollment":20},{"nctId":"NCT01853566","phase":"PHASE4","title":"Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old","status":"COMPLETED","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2012-01","conditions":"Healthy","enrollment":13}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":80,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"GH treatment (Genotropin)","genericName":"GH treatment (Genotropin)","companyName":"Rabin Medical Center","companyId":"rabin-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Genotropin is recombinant human growth hormone (somatropin) that binds to growth hormone receptors to stimulate growth, metabolism, and body composition changes. Used for Growth hormone deficiency in children, Growth hormone deficiency in adults, Short stature due to Turner syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}